MLH1 and neoplasm: In addition to the gender, several biological characteristics argue in favor of this hypothesis, leaving technical artifacts as the sole or dominant explanation for the different mutational load very unlikely: (I) the age of onset; (II) the number of tumor-infiltrating lymphocytes in the primary and (III) the experimental follow-up study showing different vaccination efficacy in tumor-bearing MLH1−/− mice.